Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Acrux Ltd | FJY | May 17, 2024 | 0.03 | 0.00 |
Actinogen Medical Limited | 3AC | May 17, 2024 | 0.02 | 0.00 |
Akeso Inc | 4RY | May 17, 2024 | 5.70 | -1.72 |
Aligos Therapeutics, Inc. - Common stock | 5WK | May 17, 2024 | 0.59 | -2.96 |
Alphamab Oncology (HK) Limited | 3NK | May 17, 2024 | 0.61 | +5.13 |
Alterity Therapeutics Ltd | PBN | May 17, 2024 | 0.00 | 0.00 |
AnGes Inc. | AJW | May 17, 2024 | 0.21 | -6.14 |
Antengene Corporation Limited | 722 | May 17, 2024 | 0.10 | +8.51 |
Ascletis Pharma Inc. | 2VJ | May 17, 2024 | 0.15 | +7.91 |
Avacta Group Plc | RTQ1 | May 17, 2024 | 0.48 | -2.03 |
Avecho Biotechnology Limited | OEZ | May 17, 2024 | 0.00 | 0.00 |
BeiGene Ltd | 49B | May 17, 2024 | 11.90 | +0.85 |
Biofrontera AG | B8FK | May 17, 2024 | 3.40 | -12.83 |
Biomed-Lubin Wytwornia Surowic I Szczepionek S.A. | 6NQ | May 17, 2024 | 1.12 | +2.19 |
Biophytis | 6XB | May 17, 2024 | 0.00 | 0.00 |
Biotest AG | BIO3 | May 17, 2024 | 27.50 | -1.08 |
Bioton S.A. | 7U5 | May 17, 2024 | 0.85 | +1.07 |
Bioventix Plc | 51B | May 17, 2024 | 50.00 | -0.99 |
Bone Therapeutics S.A. | BT1 | May 17, 2024 | 0.01 | -7.35 |
Cellectis | ZVA | May 17, 2024 | 2.69 | -1.64 |
Celon Pharma SA | 8RP | May 17, 2024 | 3.71 | -1.20 |
Chromadex Corp | OCD1 | May 17, 2024 | 3.16 | -4.24 |
Circassia Group Plc | 82C | May 17, 2024 | 0.83 | +0.61 |
CKLIFE SCIENCES | LSI | May 17, 2024 | 0.05 | 0.00 |
Clinuvel Pharmaceuticals Ltd | UR9A | May 17, 2024 | 9.20 | -4.17 |
Clinuvel Pharmaceuticals Ltd Ordinary Shares (Australia) | UR9 | May 17, 2024 | 9.38 | +1.90 |
Csl Ltd SPONSORED ADR (Australia) | CSJA | May 17, 2024 | 84.50 | -2.87 |
CSL Ltd. | CSJ | May 17, 2024 | 169.70 | -2.82 |
CSTONE PHARMAC. DL-,0001 | PH4 | May 17, 2024 | 0.16 | +7.64 |
CYNATA THERAPEUTICS LTD Ordinary Shares(Australia) | 51S | May 17, 2024 | 0.15 | +6.43 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.